This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Errors appeared in two articles on selegiline that appeared in the December issue of the Archives. In "Selegiline Use to Prevent Progression of Parkinson's Disease" (1989;46:1275-1279), on page 1275, in the first column, in line 20 of the abstract, the word alone should have been deleted so that the sentence reads: "Patients remained on a regimen of selegiline for periods ranging from 7 to 84 months."